Genomics of Systemic Lupus Erythematosus: Insights Gained by Studying Monogenic Young-Onset Systemic Lupus Erythematosus

Rheum Dis Clin North Am. 2017 Aug;43(3):415-434. doi: 10.1016/j.rdc.2017.04.005.

Abstract

Systemic lupus erythematosus (SLE) is a systemic, autoimmune, multisystem disease with a heterogeneous clinical phenotype. Genome-wide association studies have identified multiple susceptibility loci, but these explain a fraction of the estimated heritability. This is partly because within the broad spectrum of SLE are monogenic diseases that tend to cluster in patients with young age of onset, and in families. This article highlights insights into the pathogenesis of SLE provided by these monogenic diseases. It examines genetic causes of complement deficiency, abnormal interferon production, and abnormalities of tolerance, resulting in monogenic SLE with overlapping clinical features, autoantibodies, and shared inflammatory pathways.

Keywords: Complement deficiency; DNA sensing; Genetics; Interferonopathies; Monogenic diseases; RNA sensing; Systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Autoantibodies / genetics
  • Autoimmune Diseases / immunology
  • Genetic Predisposition to Disease
  • Genomics
  • Humans
  • Lupus Erythematosus, Systemic / genetics*
  • Lupus Erythematosus, Systemic / immunology

Substances

  • Autoantibodies